Patient experience survey for choroidal melanoma trial
Part of Cancer, Eyes & vision clinical trials.
This study collects feedback from people already in the CoMpass trial for choroidal melanoma. You'll answer questions about your health and quality of life using a smartphone, laptop, or tablet.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must already be part of the AU-011-301 clinical trial
- Need a smartphone, laptop, or tablet to complete surveys
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who finished a previous trial for a type of eye cancer called early choroidal melanoma. It checks how patients are doing over time after receiving either the study treatment (bel-sar) or a placebo (sham).
This study looks back at past medical records of people diagnosed with uveal melanoma. It helps researchers learn about the typical course of the disease by analyzing what already happened in care.
This study follows people with high-risk uveal (eye) melanoma after their initial treatment to better understand relapse risk. It may help your care team track you more closely using scheduled visits and blood tests.
This trial tests a program that helps melanoma patients starting immunotherapy track their side effects and get faster access to specialists. The goal is to improve symptom management.
This study looks at how people with melanoma are feeling during the COVID-19 pandemic, including quality of life. You may be asked to share information through surveys or study contact so the researchers can understand needs and concerns.
This study asks people with melanoma (and certain related skin conditions) to complete questionnaires about quality of life, lifestyle, and mental well-being. Your answers can help researchers understand what affects day-to-day life and support for people with melanoma.
Hear when a new Choroidal Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.